Abstract

The present invention provides a process for the preparation of crystalline form of Delgocitinib and its process for the preparation of compound represented by the following structural formula-1.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS